veda eswarappa (5 Ergebnisse)

Zustand: New. In.

Paperback. Zustand: Brand New. 2013 edition. 99 pages. 9.00x6.00x0.25 inches. In Stock.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book advances biomedical innovations to address the plethora of health problems afflicting the developing world. A panoply of cultural, economic, infrastructural, and other factors prevent many interventions currently popular in the developed world from being similarly effective in the developing world. This book discusses less-traditional approaches, such as naturally based biomaterials and therapeutics, an area that has traditionally been overlooked but has also demonstrated impressive potential for health applications in recent years. This book explores precisely the kinds of applications which can enable countries like India to access more effective, inexpensive treatments while also taking more ownership of their healthcare technologies and innovations.

Taschenbuch. Zustand: Neu. Naturally Based Biomaterials and Therapeutics | The Case of India | Veda Eswarappa (u. a.) | Taschenbuch | SpringerBriefs in Public Health | ix | Englisch | 2012 | Springer | EAN 9781461453857 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | This book advances biomedical innovations to address the plethora of health problems afflicting the developing world. A panoply of cultural, economic, infrastructural, and other factors prevent many interventions currently popular in the developed world from being similarly effective in the developing world. This book discusses less-traditional approaches, such as naturally based biomaterials and therapeutics, an area that has traditionally been overlooked but has also demonstrated impressive potential for health applications in recent years. This book explores precisely the kinds of applications which can enable countries like India to access more effective, inexpensive treatments while also taking more ownership of their healthcare technologies and innovations.